Custom lentivirus production and virus handling: packaging system, titre and purity

Specifying a custom batch

1. State the packaging system and generation. Later generation systems split the packaging functions across more plasmids and reduce the risk of a replication competent event. The generation is a safety statement and belongs in the order and in the biosafety application.
2. Choose transient or integrating deliberately. An integrating vector gives lasting expression and inserts into the genome. A non integrating adenoviral vector gives high, transient expression without insertion. The experiment's duration decides.
3. Name the titre method and the cell line. Functional titre on a cell resembling yours is what predicts transduction. Physical particle counts are much higher and do not. Fix it in the order.
4. Specify purity for the target cells. Crude supernatant is adequate for robust lines and toxic to primary cells. Concentration alone concentrates the medium components too, so purification rather than concentration is what primary work needs.
5. Order the control in the same production. An empty or non targeting vector from the same run shares the preparation and its contaminants, which is what a control has to do.
6. Have the approvals before the delivery. Institutional biosafety approval, containment level and waste route, agreed and documented. This is administrative and it is the commonest cause of a delayed start.

Generation is a safety statement

Splitting packaging functions across separate plasmids reduces the chance of recombination producing a replication competent particle. Which system was used is therefore part of the risk assessment and not a technical detail.

Record it in the biosafety application and on the vial. A vector of unknown provenance is difficult to assess and difficult to justify.

Comparability between batches

Two batches of the same construct differ in titre, in purity and sometimes in behaviour. Where an experiment spans batches, that variation has to be handled by design rather than assumed away.

Order enough for the whole experiment where possible, and where not, bridge the batches with a common sample.

crispr cas9 lentivirus, and what the vector has to carry

A CRISPR lentivirus has to deliver more than a guide. The cassette carries the guide under its own small RNA promoter, Cas9 or a variant under a promoter the target cell will actually use, and a selection or reporter, and Cas9 is large enough that the whole construct pushes against what a lentiviral particle packages efficiently, which is why titre falls as the cassette grows. Two vector systems are common for that reason: all in one for convenience, or Cas9 delivered once to make a stable line and guides delivered after, which is what a library screen requires.

Lentiviral packaging plasmids, and what the generation means

A lentiviral preparation is made from a transfer plasmid carrying your cassette plus packaging plasmids supplying the rest. Second generation splits the work between one packaging plasmid and an envelope plasmid; third generation splits it further, separating rev onto its own plasmid and removing accessory genes, which is what makes the system safer and why most institutional committees expect it. The practical consequences are the transfection ratio, which is tuned per system, and the envelope choice, since VSV-G is broad and pseudotyping is what changes the tropism.

lentivirus vs aav, from the production side

From the bench the two are different projects. A lentiviral preparation is a transient transfection whose product is secreted, fragile and titred by transduction, purified gently and concentrated with losses at every step. An AAV preparation is also transfection-based but the product is sturdy, mostly cell-associated depending on serotype, purified on affinity resin or a gradient and titred by genome copies with an empty-to-full measurement beside it. Yields per litre, the analytics and the containment level all differ, which is why few laboratories make both well.

A lentivirus package, and what it should contain

A packaging order is compared on its contents rather than its title: the plasmid set and its generation, the producer cells or the expectation that you supply them, the titre promised and how it was measured, the volume and buffer, and the testing for sterility, mycoplasma and residual plasmid. Ask whether concentration is included, since a low titre preparation is the commonest disappointment, and whether the titre is functional or genome-based, because the two differ by an order of magnitude on the same tube.

Common questions

Concentrate or purify with a virus concentration kit?

Concentration raises titre and also concentrates medium components, serum and cellular debris. For primary and sensitive cells, purification is what removes the toxicity, and concentration alone frequently makes it worse.

Integrating or transient vector?

Integrating for lasting expression through division; adenoviral or other non integrating routes for high, short lived expression without insertion. Duration of the experiment usually decides.

What has to be in place before delivery?

Institutional biosafety approval covering the vector and the insert, the containment level, a waste route and trained handlers. All of it is administrative and all of it takes longer than production.

Browse by service class

• Compare Gene synthesis on advertised prices